Cardiovascular Ultrasound Market By Type (Transthoracic echocardiogram, Transesophageal echocardiogram, Stress echocardiogram, Others), By Technology (2D, 3D and 4D, Others), By Display Type (Color, Black and White), By End User (Hospitals, Cardiac Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global cardiovascular ultrasound market was valued at $2,369.27 million in 2022, and is projected to reach $4,171.12 million by 2032, registering a CAGR of 5.8% from 2023 to 2032.
Ultrasound imaging is a type of medical examination. It supports medical professionals in the identification and management of a range of illnesses. In basic terms, cardiovascular ultrasound is a non-invasive method used for diagnosis of cardiac diseases. In the procedure, a transducer is used to guide high-frequency ultrasonic waves during this operation. The inside organs are then reflected on a computer screen by the transducer, which is then placed atop the chest to pass through ultrasonic waves.
The cardiovascular ultrasound market growth is driven by rise in prevalence of cardiovascular diseases, such as heart attacks and strokes. Cardiovascular ultrasound is a key diagnostic tool for assessing heart health and detecting various cardiac conditions. In addition, ongoing advancements in ultrasound technology, including 3D and 4D imaging, improved resolution, and enhanced portability, have contributed to the increased adoption of cardiovascular ultrasound systems. These technological improvements enhance diagnostic capabilities and provide more detailed and accurate information. Thus, technological advancement in healthcare sector is anticipated to boost the growth of the market.
Moreover, the aging population is more susceptible to cardiovascular diseases. As the global population ages, there is a higher demand for diagnostic tools, including cardiovascular ultrasound, to monitor and manage cardiac health. For instance, according to Journal of American Heart Association, in January 2023, it is estimated that 70% of people over 70 years old will develop cardiovascular diseases. Thus, rise in geriatric population is expected to boost the demand for diagnostic procedures and fuels the growth of cardiovascular ultrasound market.
Additionally, cardiovascular ultrasound is a non-invasive imaging technique, which makes it more patient-friendly compared to invasive procedures. The preference for non-invasive diagnostic methods has driven the demand for cardiovascular ultrasound. Therefore, increase in number of non-invasive diagnostic procedure and rise in awareness among population regarding early diagnosis is anticipated to boost the growth of market.On the other hand, advanced cardiovascular ultrasound machines can be expensive to purchase and maintain. The high initial costs may pose a barrier to adoption, especially in regions with limited healthcare budgets or in smaller healthcare facilities. Thus, high cost of cardiovascular ultrasound machines is anticipated to hinder the growth of market.
The cardiovascular ultrasound market is segmented into type, technology, end user, and region. By type, the market is classified into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and others. Others includes fetal echocardiography and intracardiac echocardiography. Depending on technology, the market is categorized into 2D, 3D & 4D, and others. Others includes doppler ultrasound and strain imaging. Based on display type, the market is segmented into color and black & white. As per end user, the market is divided into hospital, cardiac centers, and others. Others include diagnostic center and cathaterization lab.
Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global cardiovascular ultrasound market are Canon Medical Systems Corporation, Esaote SpA, GE Healthcare, Koninklijke Philips, Siemens Healthineers, Hitachi, Samsung Healthcare, Whale Imaging, FujiFilm, and Mindray. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand their cardiovascular ultrasound market share.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular ultrasound market analysis from 2022 to 2032 to identify the prevailing cardiovascular ultrasound market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cardiovascular ultrasound market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cardiovascular ultrasound market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy TypeTransthoracic echocardiogram
Transesophageal echocardiogram
Stress echocardiogram
Others
By Technology2D
3D and 4D
Others
By Display TypeColor
Black and White
By End UserHospitals
Cardiac Centers
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Europe
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market PlayersSiemens Healthineers AG
Hitachi
FUJIFILM Corporation
Whale Imaging
GE Healthcare
Koninklijke Philips N.V
Canon Inc.
ESAOTE SPA
Samsung Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Please Note: It will take 7-10 business days to complete the report upon order confirmation.